fbpx Skip to main content

Member's Profile

BlossomHill Therapeutics, Inc.

3525 JOHN HOPKINS CT, Suite 100
SAN DIEGO,   California
United States
Membership Info
Membership Type: Industry
Membership Since: 2021
Need to make an update to your Member Profile or have a question? Contact us here: [email protected]
About BlossomHill Therapeutics, Inc.
Biotech Company
BlossomHill Therapeutics, Inc. is a small molecule drug discovery and development company focused on unmet medical needs in oncology and autoimmune disorders. The company is founded by renowned drug design and development scientist, J. Jean Cui, Ph.D. and biotech veteran, Y. Peter Li, Ph.D., M.B.A. Dr. Cui is the lead inventor of multiple oncology medicines and clinical compounds which include Crizotinib, Lorlatinib, Repotrectinib (TPX-0005), TPX-0022, TPX-0046, and TPX-0131. Drs. Cui and Li are also the founders for Turning Point Therapeutics, Inc.
Related News
No related news posted by this Member